 Charles River Laboratories International Inc. shares CRL, 0.89 slid 6 in premarket trade Wednesday, after the drug company issued a profit warning for the second quarter. The company is now expected adjusted per-share earnings to rise in the low-to-mid-single digits from the year-earlier period, down from prior guidance of mid-to-high-single-digit growth. 